Detalhe da pesquisa
1.
Rituximab response in follicular lymphoma is associated with the rs20575 polymorphism in TRAILR1 extrinsic apoptosis trigger.
Pharmacogenet Genomics
; 27(2): 70-77, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27977511
2.
Phase II trial of ofatumumab plus ESHAP (O-ESHAP) as salvage treatment for patients with relapsed or refractory classical Hodgkin lymphoma after first-line chemotherapy.
Br J Haematol
; 174(6): 859-67, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27185197
3.
Recommendations on the clinical use of bendamustine in lymphoproliferative syndromes and multiple myeloma.
Eur J Haematol
; 96(5): 532-40, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26179864
4.
The role of bone marrow biopsy and FDG-PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. Accuracy in a multicenter series of 372 patients.
Am J Hematol
; 90(8): 686-90, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25925613
5.
Intensification treatment based on early FDG-PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial.
Br J Haematol
; 167(3): 327-36, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25066542
6.
Association of polymorphisms in TRAIL1 and TRAILR1 genes with susceptibility to lymphomas.
Ann Hematol
; 93(2): 243-7, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23959437
7.
Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study.
BMC Cancer
; 13: 228, 2013 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-23651475
8.
Accuracy and prognostic impact of FDG PET/CT and biopsy in bone marrow assessment of follicular lymphoma at diagnosis: A Nation-Wide cohort study.
Cancer Med
; 12(6): 6536-6546, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36373169
9.
Role of GSTT1 and M1 null genotypes as risk factors for B-cell lymphoma: influence of geographical factors and occupational exposure.
Mol Carcinog
; 51(6): 508-13, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21681823
10.
IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice.
Int J Hematol
; 116(3): 381-392, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35551632
11.
A polymorphism in FASL is associated with rituximab response in follicular lymphoma patients.
Am J Hematol
; 91(6): E305-7, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26950187
12.
SEGHI Study: Defining the Best Surveillance Strategy in Hodgkin Lymphoma after First-Line Treatment.
Cancers (Basel)
; 13(10)2021 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34067616
13.
Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin's lymphoma patients at high risk of central nervous system disease in the rituximab era.
Eur J Haematol
; 85(4): 321-8, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20528905
14.
[Hepatitis B reactivation in an HbsAg-negative/anti-HBc-positive patient with B-cell non-Hodgkin lymphoma receiving chemotherapy with rituximab]. / Reactivación de la hepatitis B en un paciente HBsAg negativo/antiHBc positivo con linfoma B que recibió quimioterapia con rituximab.
Gastroenterol Hepatol
; 33(5): 377-81, 2010 May.
Artigo
em Espanhol
| MEDLINE | ID: mdl-20363054
15.
Fludarabine, cyclophosphamide, and mitoxantrone as initial therapy of chronic lymphocytic leukemia: high response rate and disease eradication.
Clin Cancer Res
; 14(1): 155-61, 2008 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18172266
16.
Inhibition of proteasome by bortezomib causes intracellular aggregation of hepatic serpins and increases the latent circulating form of antithrombin.
Lab Invest
; 88(3): 306-17, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18195690
17.
Evaluation of four rapid methods for hemoglobin screening of whole blood donors in mobile collection settings.
Transfus Apher Sci
; 36(3): 235-42, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17556020
18.
Bone marrow biopsy superiority over PET/CT in predicting progression-free survival in a homogeneously-treated cohort of diffuse large B-cell lymphoma.
Cancer Med
; 6(11): 2507-2514, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28960797
19.
Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy.
Oncotarget
; 7(9): 10174-81, 2016 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26840087
20.
Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis.
Blood
; 109(10): 4258-63, 2007 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17244682